Philips broadens Inturis for CardiologyEyeing the growing demand among smaller hospitals for scalable digital image management solutions, Philips Medical Systems North America has introduced two additions to its Inturis for Cardiology integrated
Eyeing the growing demand among smaller hospitals for scalable digital image management solutions, Philips Medical Systems North America has introduced two additions to its Inturis for Cardiology integrated image and information system product line. Inturis NT is an entry-level solution for small to medium facilities with a single cath lab system that are seeking a cost-effective way to replace film with digital imaging and storage, according to the Shelton, CT-based firm. Inturis Lite is designed for departments with two to three labs and moderate imaging volume that want networking capabilities.
Philips has also released an advanced version of its original Inturis On-line system, Inturis On-line 2.2, for larger, high-volume departments with multiple labs from various manufacturers. All three products debuted at the TransCatheter Cardiovascular Therapeutics meeting in Washington, DC, last month.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.